Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clopidogrel resistance--risk factor in patients with acute coronary syndromes].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi - 1 Jan 2000

Costache Irina luliana, Rusu Cristina, Ivanov I, Popescu Roxana, Petriş A

Abstract excerpt

Clopidogrel is an ADP receptor antagonist, an inhibitor of platelet activation and aggregation. The effect is due to its selective and irreversible blockade of the P2Y12 receptor. The concept of clopidogrel resistance emerged since several years ago. This biological finding has a very important impact especially in patients with acute coronary syndromes, explaining by this their worse evolution. Mechanisms of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP3A

Share to Platelet Aggregation

Share to Platelet Aggregation Inhibitors

Share to Receptors, Purinergic P2Y12

Share to Ticlopidine

Share to Treatment Failure

Source

Identifiers

PMID: 23077924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clopidogrel resistance--risk factor in patients with acute coronary syndromes].PMID 23077924Read ↗

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).Semantic proximity Read ↗

[Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention].Semantic proximity Read ↗

Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?Semantic proximity Read ↗

P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialists.Semantic proximity Read ↗

Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance.Semantic proximity Read ↗

Genetic determinants of on-clopidogrel high platelet reactivity.Semantic proximity Read ↗

[The effects of cytochrome P450 2C19 genetic polymorphism on clopidogrel resistance and recent prognosis of patients with acute coronary syndrome].Semantic proximity Read ↗

Review of aspirin and clopidogrel resistance in peripheral arterial disease.Semantic proximity Read ↗

Optimisation of anti-platelet therapy in acute coronary syndromesSemantic proximity Read ↗

The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population.Semantic proximity Read ↗

[CLINICAL AND PHARMACOLOGICAL FACTORS INFLUENCING RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH CARDIOVASCULAR DISEASES].Semantic proximity Read ↗

Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.